Friday, Mar 29, 2024 | Last Update : 03:58 PM IST

itolizumab

DGCI okays Itolizumab drug for restricted emergency use on COVID patients

Biocon, a domestic biopharmaceutical company, has been manufacturing and marketing the drug.

11 Jul 2020 6:53 PM

ADVERTISEMENT
ADVERTISEMENT